Sun Pharma new plant inaugurated in Bangladesh
This is the company's second investment in Bangladesh with a production capacity of over 1 billion tablets and capsules per year.
Sun Pharma
Advertisement
Dhaka: India has been a credible partner in the growth story of Bangladesh's pharmaceutical industry, its envoy here said on Saturday as a new plant of a leading Indian pharmaceutical company Sun Pharma was inaugurated in this country.
Private Industry and Investment Adviser of Bangladesh Prime Minister Salman F Rahman and Indian High Commissioner to Bangladesh Pranay Verma jointly inaugurated the new plant of Sun Pharma at Meghna Industrial Economic Zone in the Sonargaon upazila of Narayanganj district at the bank of the river Meghna adjacent to the Dhaka-Chittagong highway, the UNB news agency reported.
Sun Pharma is the world's fourth-largest specialty generic pharmaceutical company with operations in over 100 countries.
This is the company's second investment in Bangladesh with a production capacity of over 1 billion tablets and capsules per year, according to PTI.
Verma noted that India has been a credible partner in the growth story of Bangladesh's pharmaceutical industry meeting about 30 per cent of the Active Pharmaceutical Ingredients (API) demand of Bangladesh.
He stressed that the plant, which is the first pharmaceutical unit in any Economic Zone of Bangladesh, is not just a testament to India's continued commitment to promote partnership with Bangladesh, but also reflects the growing interest among Indian businesses to invest in Bangladesh.
Verma noted the strong bilateral cooperation in the health sector, including the close engagement during the COVID-19 pandemic when India supplied vaccines under 'Vaccine Maitri' and Oxygen Express trains to Bangladesh, while Bangladesh gifted critical medicines to India.
Recognising the significant progress made by Bangladesh's pharmaceutical industry in the last few decades, the High Commissioner underscored the emergence of Bangladesh as a key player in generic drug manufacturing, the report said.
With a renewed focus on domestic production backed by a host of government incentives, Verman said there are ample opportunities for Indian manufacturers to establish business partnerships with Bangladesh companies in the form of Joint Ventures, joint R&D efforts and technology tie-ups.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.